Zollinger-Ellison Syndrome (Hypergastrinemia): Symptoms, Causes, and Treatment

What is Zollinger-Ellison Syndrome (Hypergastrinemia)?

Zollinger-Ellison Syndrome (ZES) is a rare condition where one or more tumors, called gastrinomas, form in the pancreas or the upper part of the small intestine (duodenum). These tumors secrete large amounts of the hormone gastrin, which stimulates the stomach to produce excessive acid. This leads to severe peptic ulcers, diarrhea, and other digestive symptoms. Hypergastrinemia refers to the elevated levels of gastrin in the blood, which is the hallmark of this syndrome.

ZES is often associated with Multiple Endocrine Neoplasia Type 1 (MEN1), a genetic disorder that increases the risk of tumors in the endocrine system. While ZES can occur at any age, it is most commonly diagnosed between the ages of 30 and 60. Early diagnosis and treatment are crucial to manage symptoms and prevent complications like perforation of the stomach or intestines.

Source: Mayo Clinic, National Institutes of Health (NIH)

Common Causes

Zollinger-Ellison Syndrome is primarily caused by gastrin-secreting tumors (gastrinomas). However, several underlying conditions and factors can contribute to the development of these tumors or hypergastrinemia. These include:

• Gastrinomas: Tumors in the pancreas or duodenum that produce excess gastrin. About 60-70% of gastrinomas are malignant (cancerous) and can spread to other organs like the liver.
• Multiple Endocrine Neoplasia Type 1 (MEN1): A genetic syndrome that causes tumors in the endocrine glands, including the parathyroid, pancreas, and pituitary. About 25-30% of ZES cases are linked to MEN1.
• Sporadic gastrinomas: Tumors that occur without a genetic cause, accounting for about 70-75% of ZES cases.
• Chronic atrophic gastritis: A condition where the stomach lining is inflamed and thinned, sometimes leading to increased gastrin production.
• Helicobacter pylori infection: While this bacteria typically causes ulcers by other mechanisms, chronic infection can sometimes lead to hypergastrinemia.
• Use of proton pump inhibitors (PPIs): Long-term use of these acid-reducing medications can sometimes cause elevated gastrin levels, though this is usually not as severe as in ZES.
• Chronic kidney disease: Impaired kidney function can reduce the clearance of gastrin from the blood, leading to elevated levels.
• Autoimmune conditions: Conditions like pernicious anemia can lead to reduced stomach acid, which in turn can cause the body to produce more gastrin.
• Gastric outlet obstruction: Blockages in the stomach or intestines can sometimes lead to increased gastrin production.
• Short bowel syndrome: In some cases, surgical removal of parts of the intestine can lead to hormonal imbalances, including elevated gastrin.

Source: National Cancer Institute (NCI), Cleveland Clinic

Associated Symptoms

The symptoms of Zollinger-Ellison Syndrome are primarily related to the overproduction of stomach acid and the presence of ulcers. Common symptoms include:

• Severe abdominal pain: Often due to peptic ulcers in the stomach, duodenum, or even the jejunum (unlike typical ulcers, which rarely occur beyond the duodenum).
• Diarrhea: Excess stomach acid can damage the intestines, leading to chronic, watery diarrhea.
• Heartburn or acid reflux: The excessive acid can flow back into the esophagus, causing a burning sensation.
• Nausea and vomiting: Often due to irritation of the stomach lining or ulcers.
• Weight loss: Chronic diarrhea, pain, and reduced appetite can lead to unintentional weight loss.
• Bleeding in the digestive tract: Ulcers can erode blood vessels, leading to blood in the stool (black or tarry stools) or vomit (coffee-ground appearance or bright red blood).
• Perforation of the stomach or intestines: Severe ulcers can create holes in the digestive tract, leading to severe pain and infection (peritonitis).
• Gastroesophageal reflux disease (GERD): Chronic acid reflux can damage the esophagus over time.
• Malabsorption: Damage to the intestines can impair the absorption of nutrients, leading to deficiencies.

In cases where ZES is associated with MEN1, additional symptoms may include:

• Kidney stones (due to hyperparathyroidism).
• Bone pain or fractures (due to hyperparathyroidism).
• Headaches or vision problems (due to pituitary tumors).

Source: Johns Hopkins Medicine, World Health Organization (WHO)

When to See a Doctor

Zollinger-Ellison Syndrome is rare, but its symptoms can be severe and life-threatening if left untreated. You should seek medical attention if you experience any of the following:

• Persistent or severe abdominal pain that doesn’t improve with over-the-counter medications.
• Chronic diarrhea that lasts for weeks or recurs frequently.
• Unexplained weight loss (more than 5% of body weight over 6-12 months).
• Blood in your stool or vomit (this is a medical emergency).
• Difficulty swallowing or persistent heartburn that doesn’t respond to treatment.
• Symptoms of complications, such as severe vomiting, fever, or rigid abdomen (which may indicate perforation).
• A family history of MEN1 or ZES, especially if you develop digestive symptoms.

If you have a history of peptic ulcers that are recurrent, unusually located (e.g., in the jejunum), or resistant to standard treatments, your doctor may suspect ZES and refer you for further testing.

Source: Centers for Disease Control and Prevention (CDC)

Diagnosis

Diagnosing Zollinger-Ellison Syndrome involves a combination of blood tests, imaging studies, and sometimes endoscopic procedures. Here’s how doctors typically evaluate the condition:

1. Blood Tests

• Fasting gastrin level: The primary test for ZES. Gastrin levels are measured after fasting for at least 12 hours. Levels higher than 1,000 pg/mL strongly suggest ZES, but lower elevations may require further testing.
• Secretin stimulation test: Secretin (a hormone) is injected, and gastrin levels are measured. In ZES, gastrin levels rise significantly after secretin injection, whereas they typically decrease or stay the same in other conditions.
• Chromogranin A: A marker for neuroendocrine tumors, which can support the diagnosis.
• Calcium levels: Elevated calcium may indicate MEN1, which is often associated with ZES.

2. Imaging Studies

• CT scan or MRI: Used to locate tumors in the pancreas or duodenum.
• Octreotide scan: A radioactive tracer is injected to help identify neuroendocrine tumors.
• Endoscopic ultrasound (EUS): Combines endoscopy and ultrasound to detect small tumors in the pancreas or duodenum.
• Somatostatin receptor scintigraphy (SRS): A specialized scan to detect gastrinomas.

3. Endoscopic Procedures

• Upper endoscopy: A flexible tube with a camera is used to examine the stomach and duodenum for ulcers or tumors. Biopsies may be taken to check for H. pylori or other conditions.
• Capsule endoscopy: A small camera in a pill is swallowed to examine the small intestine for ulcers or tumors.

4. Genetic Testing

If MEN1 is suspected (e.g., due to family history or other endocrine tumors), genetic testing may be recommended to check for mutations in the MEN1 gene.

Source: National Center for Biotechnology Information (NCBI), Mayo Clinic

Treatment Options

The treatment of Zollinger-Ellison Syndrome focuses on reducing stomach acid production, managing tumors, and addressing any complications. Treatment plans are often individualized based on the severity of symptoms, the presence of MEN1, and whether the tumors have spread.

Medical Treatments

• Proton pump inhibitors (PPIs): High doses of PPIs (e.g., omeprazole, pantoprazole) are the first-line treatment to reduce stomach acid. These are often taken twice daily.
• H2 blockers: Medications like famotidine or ranitidine may be used in addition to PPIs or if PPIs are not tolerated.
• Octreotide: A synthetic hormone that can reduce gastrin secretion in some cases, particularly if tumors are not resectable.
• Surgery: Surgical removal of gastrinomas is the only curative treatment. This may involve removing part of the pancreas, duodenum, or nearby lymph nodes. Surgery is more likely to be curative if the tumors haven’t spread.
• Chemotherapy or targeted therapy: For metastatic or aggressive tumors, medications like streptozocin, 5-fluorouracil, or everolimus may be used.
• Liver-directed therapies: If tumors have spread to the liver, treatments like embolization (blocking blood flow to tumors) or radiofrequency ablation (using heat to destroy tumors) may be options.

Home and Lifestyle Management

• Dietary changes: Avoid foods that trigger acid production, such as spicy foods, caffeine, alcohol, and fatty or fried foods. Eat smaller, more frequent meals to reduce stomach acid secretion.
• Hydration: Chronic diarrhea can lead to dehydration, so drink plenty of fluids and consider oral rehydration solutions if needed.
• Monitor symptoms: Keep a symptom diary to track pain, diarrhea, and other issues. This can help your doctor adjust treatments.
• Avoid smoking: Smoking can worsen ulcers and acid reflux.
• Stress management: Stress can exacerbate digestive symptoms, so techniques like meditation, yoga, or counseling may help.

Management of MEN1-Associated ZES

If ZES is part of MEN1, treatment will also address other endocrine tumors, such as:

• Parathyroid tumors (treated with surgery or medications to manage calcium levels).
• Pituitary tumors (treated with medications, surgery, or radiation).

Source: American Society of Clinical Oncology (ASCO), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Prevention Tips

While Zollinger-Ellison Syndrome cannot always be prevented, especially in cases linked to genetic conditions like MEN1, there are steps you can take to reduce your risk or catch the condition early:

• Genetic counseling: If you have a family history of MEN1 or ZES, consider genetic counseling and testing. Early detection of MEN1 can lead to earlier surveillance and treatment.
• Regular screenings: If you have MEN1, regular screenings for gastrinomas, parathyroid tumors, and pituitary tumors are essential. This may include blood tests, imaging, and endoscopies.
• Manage H. pylori infections: If you have a history of H. pylori infection, follow your doctor’s treatment plan to eradicate the bacteria and reduce the risk of complications.
• Avoid unnecessary PPI use: While PPIs are safe for short-term use, long-term use should be monitored by a doctor to avoid hypergastrinemia.
• Healthy lifestyle: Maintain a balanced diet, avoid smoking, limit alcohol, and manage stress to support overall digestive health.
• Stay informed: If you have a history of peptic ulcers or digestive issues, educate yourself about the symptoms of ZES and discuss any concerns with your doctor.

Source: World Health Organization (WHO), CDC Office of Genomics

Emergency Warning Signs

Zollinger-Ellison Syndrome can lead to life-threatening complications. Seek immediate medical attention if you experience any of the following emergency warning signs:

• Severe abdominal pain that comes on suddenly and is unbearable. This could indicate a perforated ulcer, which is a medical emergency requiring surgery.
• Vomiting blood (hematemesis) or blood that looks like coffee grounds. This suggests significant bleeding in the stomach or esophagus.
• Black, tarry stools (melena) or bright red blood in the stool. This indicates bleeding in the digestive tract, which can lead to shock if untreated.
• Signs of shock, such as:
  • Rapid heartbeat or weak pulse.
  • Low blood pressure (feeling dizzy or faint).
  • Cold, clammy skin.
  • Confusion or loss of consciousness.
• Severe dehydration from chronic diarrhea, characterized by:
  • Extreme thirst.
  • Dry mouth or skin.
  • Little or no urination.
  • Sunken eyes or fatigue.
• Difficulty breathing or chest pain, which could indicate a severe complication like a perforated ulcer affecting the lungs or heart.
• High fever with abdominal rigidity, which may indicate peritonitis (infection of the abdominal cavity due to perforation).

If you or someone else experiences these symptoms, call emergency services or go to the nearest emergency room immediately. Delaying treatment can be fatal.

Source: UK National Health Service (NHS), Medscape